The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.
UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 infection...
Screening could enable early intervention
